China monoclonal antibodies market is estimated to grow at a CAGR of 9.2% during the forecast period. A significant rise in cancer incidences and increasing launches of biosimilars are some potential factors accelerating market growth. To increase access to potential oncology treatment, the Chinese authorities have been granted approvals of monoclonal antibodies. For instance, in January 2020, Bio-Thera Solutions, Ltd. declared that China National Medical Products Administration (NMPA) launched QLETLI, a biosimilar to Humira (adalimumab).

Request a free sample of our report on China Monoclonal Antibodies Market: https://www.omrglobal.com/request-sample/china-monoclonal-antibodies-market

It is the first adalimumab biosimilar granted by the NMPA which is indicated to treat three autoimmune diseases, which include ankylosing spondylitis, plaque psoriasis, and rheumatoid arthritis. It is the company’s first biosimilar gained regulatory approval, and it is the second biosimilar which is approved in China by the NMPA. The company is developing multiple additional planned biosimilars, which include biosimilars to Avastin and to Actemra/RoActemra. These are both currently being assessed in global Phase III clinical trials. The company is also pursuing biosimilars to Stelara and Simponi.

A full report of China Monoclonal Antibodies Market Is available at https://www.omrglobal.com/industry-reports/china-monoclonal-antibodies-market

China Monoclonal Antibodies Market Segmentation

By Source

Murine

Chimeric

Human

Humanized

By Application

Cancer

Infectious Diseases

Auto-Immune Diseases

Inflammatory Diseases

Others

Company Profiles

Amgen Inc.

Anhui Anke Biotechnology (Group) Co., Ltd.

AstraZeneca plc

CStone Pharmaceuticals

GenorBioPharma Co., Ltd.

Harbour BioMed (HBM)

Innovent Biologics, Inc.

Merck & Co., Inc.

Pfizer Inc.

Shanghai Fosun Pharmaceutical (Group) Co., Ltd.

For more customized data, request for report customization @ https://www.omrglobal.com/report-customization/china-monoclonal-antibodies-market

About Us:

Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting, and other research-based services.

For More Information, Visit https://www.omrglobal.com/

Media Contact:

Company Name: Orion Market Research

Contact Person: Mr. Anurag Tiwari

Email: [email protected]

Contact no: +91 780-304-0404